Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Laura J. Esserman, David M. Ota, Tao Yu et al.|UNC Libraries|2020Cited by 0